CTC
MEDP icon

Central Trust Company’s Medpace MEDP Stock Holding History

Central Trust Company’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.9K Buy
132
+19
+17% +$8.77K ﹤0.01% 816
2026
Q1 		$54.3K Sell
113
-1
-0.9% -$512 ﹤0.01% 829
2025
Q4 		$64K Sell
114
-36
-24% -$20.4K ﹤0.01% 775
2025
Q3 		$77.1K Hold
150
– – ﹤0.01% 735
2025
Q2 		$47.1K Sell
150
-35
-19% -$10.5K ﹤0.01% 816
2025
Q1 		$56.4K Sell
185
-33
-15% -$11.1K ﹤0.01% 764
2024
Q4 		$72.4K Sell
218
-152
-41% -$51.5K ﹤0.01% 722
2024
Q3 		$124K Sell
370
-64
-15% -$24.3K ﹤0.01% 620
2024
Q2 		$179K Sell
434
-319
-42% -$126K ﹤0.01% 566
2024
Q1 		$304K Sell
753
-201
-21% -$70.7K 0.01% 499
2023
Q4 		$292K Sell
954
-198
-17% -$53.4K 0.01% 491
2023
Q3 		$279K Buy
+1,152
New +$295K 0.01% 495
2022
Q3 		– Sell
-3
Closed – – 1370
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1420
2022
Q1 		$0 Sell
3
-72
-96% -$11.9K ﹤0.01% 1432
2021
Q4 		$16K Hold
75
– – ﹤0.01% 984
2021
Q3 		$14K Hold
75
– – ﹤0.01% 980
2021
Q2 		$13K Buy
+75
New +$12.9K ﹤0.01% 976
2021
Q1 		– Sell
-40
Closed -$6K – 1128
2020
Q4 		$6K Hold
40
– – ﹤0.01% 940
2020
Q3 		$4K Sell
40
-10
-20% -$1.16K ﹤0.01% 961
2020
Q2 		$5K Buy
+50
New +$4.25K ﹤0.01% 928

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Central Trust Company's MEDP Position: Q2 2026 in Review

Central Trust Company increased its Medpace (MEDP) stake by 17% in Q2 2026, buying an estimated $8.77K and bringing the position to 132 shares worth $69.9K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

Central Trust Company first reported a position in MEDP in Q2 2020 and has held it in 20 quarters since. The position peaked at $304K in Q1 2024. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Central Trust Company held 132 shares of Medpace worth $69.9K as of Q2 2026.
  • Central Trust Company bought 19 Medpace shares in Q2 2026, an estimated $8.77K.
  • Medpace made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #816 holding.
  • Central Trust Company first reported a position in Medpace in Q2 2020 and has held it in 20 quarters since.
  • Central Trust Company's Medpace position peaked at $304K in Q1 2024.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.